NEWS > A Word from the CEO
04 April 2024

A Word from the CEO

10,000 Patients Enrolled in Our Pan-Canadian Oncology Databank


I am thrilled to share a significant milestone in the journey of Exactis Innovation. This month, we marked the enrollment of the 10,000th patient in our pan-Canadian, longitudinal oncology databank. This achievement is not just a number but a testament to a decade of unwavering dedication, countless hours of hard work, and the relentless pursuit of a vision that began ten years ago.

 When we embarked on this journey, we set out with a bold ambition: to transform cancer care through personalized medicine. Today, having enrolled 10,000 patients, we stand at a pivotal moment where our data is poised to unlock insights into the use of targeted therapies. This milestone brings us closer to realizing the dream of delivering precise, personalized treatment plans for cancer patients across Canada.

 The journey to this point has been challenging yet inspiring. It is a reflection of the collective effort of our team, healthcare partners, and, most importantly, the patients who have entrusted us with their data in the hope of a better future for cancer care. To each one of you, I extend my deepest gratitude. Your participation and support have been the cornerstone of our progress.

 With this rich repository of oncology data, Exactis Innovation is uniquely positioned to address the most pressing research questions in the field of molecular diagnostics and targeted therapies. Our work has the potential not only to advance scientific understanding but also to significantly improve the healthcare system for cancer patients.

 As we celebrate this milestone, let us also look to the future with renewed commitment and optimism. The road ahead is filled with opportunities to make an even greater impact. I am confident that together, we will continue to push the boundaries of innovation and pave the way for a new era in cancer treatment.

 Thank you for being a part of this remarkable journey. Your continued support fuels our mission to revolutionize cancer care and bring hope to countless lives.


Kostas Trakas

CEO, Exactis Innovation